1. Home
  2. PRME vs BIT Comparison

PRME vs BIT Comparison

Compare PRME & BIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRME
  • BIT
  • Stock Information
  • Founded
  • PRME 2019
  • BIT 2013
  • Country
  • PRME United States
  • BIT United States
  • Employees
  • PRME N/A
  • BIT N/A
  • Industry
  • PRME Medicinal Chemicals and Botanical Products
  • BIT Trusts Except Educational Religious and Charitable
  • Sector
  • PRME Health Care
  • BIT Finance
  • Exchange
  • PRME Nasdaq
  • BIT Nasdaq
  • Market Cap
  • PRME 693.5M
  • BIT 616.7M
  • IPO Year
  • PRME 2022
  • BIT N/A
  • Fundamental
  • Price
  • PRME $4.65
  • BIT $13.37
  • Analyst Decision
  • PRME Buy
  • BIT
  • Analyst Count
  • PRME 6
  • BIT 0
  • Target Price
  • PRME $8.88
  • BIT N/A
  • AVG Volume (30 Days)
  • PRME 2.9M
  • BIT 92.4K
  • Earning Date
  • PRME 11-11-2025
  • BIT 01-01-0001
  • Dividend Yield
  • PRME N/A
  • BIT 9.36%
  • EPS Growth
  • PRME N/A
  • BIT N/A
  • EPS
  • PRME N/A
  • BIT N/A
  • Revenue
  • PRME $4,961,000.00
  • BIT N/A
  • Revenue This Year
  • PRME $179.58
  • BIT N/A
  • Revenue Next Year
  • PRME N/A
  • BIT N/A
  • P/E Ratio
  • PRME N/A
  • BIT N/A
  • Revenue Growth
  • PRME 739.42
  • BIT N/A
  • 52 Week Low
  • PRME $1.11
  • BIT $13.65
  • 52 Week High
  • PRME $5.17
  • BIT $15.97
  • Technical
  • Relative Strength Index (RSI)
  • PRME 67.08
  • BIT 31.03
  • Support Level
  • PRME $3.09
  • BIT $13.62
  • Resistance Level
  • PRME $4.18
  • BIT $13.99
  • Average True Range (ATR)
  • PRME 0.33
  • BIT 0.16
  • MACD
  • PRME 0.12
  • BIT 0.00
  • Stochastic Oscillator
  • PRME 80.00
  • BIT 8.82

About PRME Prime Medicine Inc.

Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.

About BIT BlackRock Multi-Sector Income Trust of Beneficial Interest

BlackRock Multi-Sector Income Trust is a closed-end investment management company. It invests on behalf of its clients. The fund's primary investment objective is to provide a high level of current income, with a secondary objective of capital appreciation. The company seeks to achieve its investment objectives by investing, under normal market conditions, a majority of its assets in loan and debt instruments and other investments with similar economic characteristics. Its portfolio consists of Corporate Bonds, Asset-Backed Securities, Preferred Securities, and others.

Share on Social Networks: